Overjet has raised $131.0M in total across 4 funding rounds.
Overjet's investors include Arkitekt Ventures, bloom venture partners, Crosslink Capital, General Catalyst, Ignition Partners, Insight Partners, March Capital, Max Ventures, Threshold Ventures, Trust Ventures, Uncork Capital, Y Combinator.
Overjet is a dental AI company founded in 2018 that builds an FDA-cleared platform to analyze dental X-rays, detect diseases like cavities and bone loss, and support providers and payers in delivering precise, patient-centric care.[1][2][3] It serves dentists, dental service organizations (DSOs), dental groups, insurance companies, and health plans covering over 120 million members, solving problems like inconsistent diagnoses, administrative inefficiencies, and poor patient communication through AI-driven visualizations, voice documentation, and claims review.[2][3][4] With over $130 million raised, including a record $53 million Series C, Overjet powers thousands of practices nationwide, boosting case acceptance, standardizing care, and improving outcomes via tools like Dental AI Assist and Voice AI Suite.[2][4]
Overjet emerged in 2018 from Harvard Innovation Labs when MIT computer scientists, including CEO Wardah Inam (PhD), and Harvard dentists united to tackle dentistry's diagnostic challenges, sparked by Inam's personal bad dental experience that highlighted the need for precision medicine.[2][6] Co-founder Alexander Jelicich (MIT '13) joined to develop AI for X-ray analysis, initially focusing on insurance claims before expanding to in-office tools.[6] Early traction came from FDA clearances for cavity detection, bone loss quantification, and calculus, enabling partnerships with major players like Delta Dental, Guardian, and top DSOs; the company quickly scaled to analyze tens of millions of X-rays and serve nationwide practices.[4][6][7]
Overjet rides the AI-in-healthcare wave, specifically transforming dentistry—a $150B+ U.S. market ripe for digitization amid clinician shortages and rising DSO dominance—by quantifying subjective X-ray reads for precision medicine.[1][5][6] Timing aligns with FDA's growing AI approvals and payer demands for data-driven claims, positioning Overjet as the standard-setter processing massive multimodal data (images/text) that others can't match.[3][4] It influences the ecosystem by partnering with top insurers (75M+ patients) and DSOs, fostering AI adoption, streamlining workflows, and enabling universal dentistry OS; this reduces disparities in care while boosting efficiency in a fragmented field.[2][6]
Overjet is poised to dominate dental AI with its $130M+ war chest fueling Voice AI expansion, payer integrations, and a full-stack OS connecting providers, payers, and schools.[2][4] Trends like multimodal AI, real-time clinical intelligence, and regulatory tailwinds will accelerate growth, potentially capturing more of the DSO/insurer market as AI becomes table stakes—"those that embrace it thrive, others fade."[2] Its influence could evolve from diagnostic leader to ecosystem orchestrator, humanizing Overjet's origin as a precision revolution sparked by real-world pain, now scaling oral health globally.[6]
Overjet has raised $131.0M across 4 funding rounds. Most recently, it raised $53.0M Series C in March 2024.
